Brief: Dicot Overallotment Issue Fully Subscribed
Sept 27 (Reuters) - Dicot AB DICOT.TE :
* DICOT'S OVERALLOTMENT ISSUE FULLY SUBSCRIBED
* THROUGH OVERALLOTMENT ISSUE, COMPANY WILL RECEIVE
APPROXIMATELY
SEK 2 MILLION BEFORE ISSUE COSTS
Source text for Eikon: ID:nWkr9nyVHq
Further company coverage: DICOT.TE
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Dicot Pharma AB
See all newsBrief: Dicot Pharma Q2 Net Sales Sek 0.0 Million
Brief: Dicot Pharma Submits CTA In EU For Phase 2b Study Of LIB-01
Brief: Dicot Pharma Recruits Cecilia Driving As CFO
Brief: Dicot Pharma Gets FDA Clearance To Start First Part Of Phase 2B Study With Lib-01 In U.S.
Brief: Dicot Pharma Announces Outcome In Oversubscribed Rights Issue